emrelis

Generic: telisotuzumab vedotin

Labeler: abbvie inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name emrelis
Generic Name telisotuzumab vedotin
Labeler abbvie inc.
Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

telisotuzumab vedotin 100 mg/mL

Manufacturer
AbbVie Inc.

Identifiers & Regulatory

Product NDC 0074-1055
Product ID 0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761384
Listing Expiration 2026-12-31
Marketing Start 2025-05-14

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00741055
Hyphenated Format 0074-1055

Supplemental Identifiers

RxCUI
2714245 2714251 2714253 2714255
UNII
976X9VXC3Z

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name emrelis (source: ndc)
Generic Name telisotuzumab vedotin (source: ndc)
Application Number BLA761384 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 100 mg/mL
source: ndc
Packaging
  • 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE
source: ndc

Packages (1)

0074-1055-01 1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01) / 1 mL in 1 VIAL, SINGLE-DOSE

Ingredients (1)

telisotuzumab vedotin (100 mg/mL)

Linked Drug Pages (1)

EMRELIS ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "998985bb-7cd1-4e80-bd08-8fc7c503f982", "openfda": {"unii": ["976X9VXC3Z"], "rxcui": ["2714245", "2714251", "2714253", "2714255"], "spl_set_id": ["bc04f980-3957-4e35-ab81-8ec2ffe87215"], "manufacturer_name": ["AbbVie Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (0074-1055-01)  / 1 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "0074-1055-01", "marketing_start_date": "20250514"}], "brand_name": "EMRELIS", "product_id": "0074-1055_998985bb-7cd1-4e80-bd08-8fc7c503f982", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "product_ndc": "0074-1055", "generic_name": "Telisotuzumab Vedotin", "labeler_name": "AbbVie Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMRELIS", "active_ingredients": [{"name": "TELISOTUZUMAB VEDOTIN", "strength": "100 mg/mL"}], "application_number": "BLA761384", "marketing_category": "BLA", "marketing_start_date": "20250514", "listing_expiration_date": "20261231"}